
zzso for the treatment of chronic zzso B zzso in zzso patients is complex due to the lack of controlled trials and the dual activity of therapeutic agents on both zzso Thus, proposals for optimal zzso therapy in zzso patients should be pragmatic using the knowledge from zzso zzso and zzso zzso zzso There are four approved drugs for the treatment of zzso which include zzso alpha zzso zzso zzso zzso zzso and zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso are approved for zzso and active against zzso Studies with zzso are limited in zzso zzso patients but suggest a decreased response compared with zzso zzso zzso zzso and zzso are effective against zzso but are associated with a high rate of zzso zzso zzso zzso and zzso are effective against zzso and zzso zzso with a zzso resistance profile shown for zzso and zzso zzso zzso or zzso are the preferable drugs in zzso zzso patients who do not require zzso zzso Combination of zzso plus zzso or zzso should be proposed in patients with therapeutic indication for both zzso zzso should be included in the zzso zzso of patients with zzso resistance to zzso 

